David Barneda Ciurana
Member of the Research Line Cancer profiling
Email: david.barneda@umedicina.cat
ORCID: 0000-0002-4436-4100
David Barneda is a lecturer at the University of Vic – Central University of Catalonia (UVic-UCC). His research focuses on the cell biology of lipids in a range of biomedical contexts.
Among other studies, he has worked on the molecular mechanisms of lipid droplet growth and function in adipocytes and stem cells, as well as the roles of phospholipid metabolism and signalling in cancer and immune cells. This includes research on the mechanisms and functional roles underlying the intriguing acyl-chain specificity of phosphoinositides, carried out in the laboratory of Phill Hawkins and Len Stephens, pioneers of PI3K signalling.
David Barneda holds a BSc in Chemistry from the University of Girona and a BSc and PhD in Biochemistry and Molecular Biology from the Autonomous University of Barcelona (UAB). From 2011 to 2022 he was a postdoctoral researcher at Imperial College London, Queen Mary University of London, AstraZeneca and the Babraham Institute. In 2023, he joined the Faculty of Medicine at UVic-UCC, where he teaches Human Physiology in the Medicine and Odontology degrees.
My last happenings:
Exploiting Hormesis for Plasma-treated Hydrogel Therapeutic platforms (HormeTic)
Subprojects: Subproject 1: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for cancer treatment (HormOnc)". Subproject 2: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal)". Original Title (English): Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal). Objective: Innovating in the healing of complex wounds. TR2Lab research team members: Albert Espona-Noguera (Principal Investigator). Cristina Canal (PI1 of Subproject 1) & Francesco Tampieri (PI2 of Subproject 1). Members of TR2Lab who participate in this project: Elisabet Sarri, Laia Bosch, Gemma Sangüesa, Francesc Sant Masoliver, Cristina Martin Mancera, David Benito Guasch, Clara Masó [...]
Lactic acid as a marker of therapeutic response
Members: Dr M. Parera (CHV), Dr I. Barba (Medicina UVic) Financial support: APR-IRIS-CC The Project “Lactic acid as a marker of therapeutic response” has received approval from the IRIS-CC ethics committee and will start recruiting patients in earnest. The project is a collaboration between Consorci Hospitalari de Vic (Dr M. Parera) and the faculty of medicine UVic (Dr I.Barba) and will evaluate lactic acid as a potential marker of therapeutic response in non-small cell lung cancer patients. We would like to thank all the patients who selflessly participate in this project. El projecte «L'àcid làctic com a [...]
Predictors of Recurrence and Survival in Endometrial Cancer: A 22-Year Single-Center Cohort Study
Funding: Industrial Doctorates Plan of the Government of Catalonia (Industrial Doctorate; DI-2024-00104) Osona Contra el Càncer (OCC) «Ajuts per a Projectes de Recerca Interns» call of the Fundació d’Estudis Superiors en Ciències de la Salut (FESS; APR-2025-FESS) Authors: E. Sardo (1,6,7,8,), M. Alejo Sánchez (2,7), M. Parera Roig (1,6,7,8,), C. Cruz Zambrano (6,7,8,), N. Espejo Herrera (2,8), K. Salas León (2), A. Canet Gómez (2), M. Armengou Ríos (2), C. Vila Díaz (2), E. Puigoriol Juvanteny (3), S. Moros Weakner (4), V. Álvarez Torrecillas (4), I. Gallego Anton (8), M.Panadès Tejero (8), M. Zarcero Estevez (5), S. Griñó [...]
